Clostridium Difficile Enterocolitis, commonly known as C diff, is a disease process that occurs following the colon’s exposure to antibiotics. C diff is difficult to treat and can be life threatening to patients. Currently, there are three basic treatment options for C Diff Colitis patients: oral dosage is effective, but requires very strong doses to reach the colon and large intestine, often causing multiple side effects due to the increased drug strength. Intravenous medication (IV) solution is also effective, but medication absorption into the colon is challenging. Retention enemas are the most effective for delivering the solution directly to the problem areas, but retention times are not long enough to effectively control the infection.
The Colorectal Delivery Device is designed to deliver a low pressure, high quality foaming solution to the infected area of the colon, with drug suspension in the target area for a longer period of time. A foaming solution was chosen as the transport media for the medication because of its ability to effectively coat the surfaces of the colon for an extended period of time.
Dr. Robert Swords is an Infectious disease physician and a medical device inventor for Mercy Research.
Dr. Jesse Taylor is a board certified Gastroenterologist with Mercy Clinic Gastroenterology - Whiteside. he attended the University of Utah School of Medicine. He is a medical device inventor for several Mercy Research projects.